Mar. Drugs 2014, 12
2629
26
Compound 3b: [α]D 102.9 (c 1.03, MeOH); HRMS (ESI) m/z calcd for C11H17O [M + H]+
165.1274, found 165.1277.
23
Compound 4b: [α]D 68.1 (c 1.00, MeOH); HRMS (ESI) m/z calcd for C17H31OSi [M + H]+
279.2139, found 279.2139.
Compound 5b: HRMS (ESI) m/z calcd for C33H62OPSi [M − Cl]+ 533.4302, found 533.4293.
meso-Alloxanthin (1c) was synthesized via condensation between 5b and (3R)-C25-acetylenic
apocarotenal 8, which was prepared by Wittig reaction of C10-dialdehyde 7 with 5a as follows.
(2E,4E,6E,8E,10E)-2,7,11-trimethyl-13-[(R)-2,6,6-trimethyl-4-triethylsilyloxycyclohex-1-en-1-yl]
trideca-2,4,6,8,10-pentaen-12-ynal (8). NaOMe (1 M in MeOH; 1.2 mL, 1.2 mmol) was added to a
solution of the (3R)-phosphonium salt 5a (409 mg, 0.73 mmol) and C10-dialdehyde 7 (100 mg,
0.61 mmol) in CH2Cl2 (10 mL) at 0 °C. After being stirred at 0 °C for 15 min, the mixture was poured
into saturated aq. NH4Cl and extracted with AcOEt. The extracts were washed with brine, dried over
Na2SO4 and evaporated to afford a residue, which was purified by flash column chromatography
(AcOEt–n-hexane, 1:4) to give the (3R)-C25-acetylenic apocarotenal 8 (165 mg, 57%) as an orange
viscous oil: UV-VIS λmax (EtOH)/nm 420; IR νmax (CHCl3)/cm−1 2170 (C≡C), 1663 (conj. CHO), 1610
and 1599 (split) (C=C), 1552 (C=C); 1H-NMR (CDCl3, 300 MHz) δ 0.61 (6H, q, J = 8 Hz, SiCH2 × 3),
0.97 (9H, t, J = 8 Hz, CH2CH3 × 3), 1.14 and 1.18 (each 3H, s, 1-gem-Me), 1.49 (1H, t, J = 12 Hz,
2-Hβ), 1.74 (1H, ddd, J = 12, 3.5, 2 Hz, 2-Hα), 1.89 (3H), 1.91 (3H) and 2.03 (6H) (each s, 5-Me, 9-Me,
13-Me and 13′-Me), 2.11 (1H, br dd, J = 17.5, 9.5 Hz, 4-Hβ), 2.30 (1H, br dd, J = 17.5, 5.5 Hz, 4-Hα),
3.94 (1H, m, 3-H), 6.32 (1H, br d, J = 12 Hz, 14-H), 6.37 (1H, d, J = 15 Hz, 12-H), 6.46 (1H, br d,
J = 11.5 Hz, 10-H), 6.66 (1H, dd, J = 15, 11.5 Hz, 11-H), 6.70 (1H, dd, J = 14.5, 11.5 Hz, 15′-H), 6.96
13
(1H, br d, J = 11.5 Hz, 14′-H), 7.03 (1H, dd, J = 14.5, 12 Hz, 15-H), 9.46 (1H, s, CHO); C-NMR
(CDCl3, 75 MHz) δ 4.82 (C × 3), 6.83 (C × 3), 9.59, 12.96, 18.17, 22.53, 28.61, 30.45, 36.53, 42.11,
47.04, 65.01, 90.10, 98.16, 121.15, 123.84, 126.60, 127.73, 131.75, 134.51, 137.02, 137.07, 137.47,
138.70, 141.26, 148.75, 194.45; HRMS (ESI) m/z calcd for C31H47O2Si (MH)+ 479.3340, found 479.3347.
Preparation of meso-alloxanthin (1c). NaOMe (1 M in MeOH; 0.24 mL, 0.24 mmol) was added to a
solution of the (3S)-phosphonium salt 5b (113 mg, 0.20 mmol) and (3R)-C25-acetylenic apocarotenal 8
(59 mg, 0.12 mmol) in CH2Cl2 (10 mL) at room temperature. After being stirred for further 15 min, the
mixture was poured into saturated aq. NH4Cl and extracted with AcOEt. The extracts were washed
with brine, dried over Na2SO4 and evaporated to afford a residue, which was purified by flash column
chromatography (AcOEt–n-hexane, 1:4) to give the TES-protected condensed product. Subsequently,
to a solution of this condensed product in dry THF (5 mL) were added AcOH (1 M in THF; 0.20 mL,
0.20 mmol) and then tetrabutylammonium fluoride (TBAF) (1 M in THF, 0.40 mL, 0.40 mmol). After
being stirred at room temperature for 2 h, the mixture was concentrated to give a residue, which was
purified by flash column chromatography (AcOEt–n-hexane–MeOH, 50:45:5) to provide meso-alloxanthin
(1c) (70 mg, quant.) as red solids. Its spectral data were identical with those of (3R,3′R)-alloxanthin
(1a) [20]. HRMS (ESI) m/z calcd for C40H53O2 [M + H]+ 565.4040, found 565.4033.